室内多重实时荧光定量PCR法与Altona诊断试剂盒检测移植患者HSV、VZV和EBV的比较

IF 2.3 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
BioMed Research International Pub Date : 2025-09-22 eCollection Date: 2025-01-01 DOI:10.1155/bmri/7109372
Reyhaneh Kalhor, Mahdi Paryan, Sirous Naeimi, Hourieh Kalhor, Hassan Noorbazargan, Samira Mohammadi-Yeganeh
{"title":"室内多重实时荧光定量PCR法与Altona诊断试剂盒检测移植患者HSV、VZV和EBV的比较","authors":"Reyhaneh Kalhor, Mahdi Paryan, Sirous Naeimi, Hourieh Kalhor, Hassan Noorbazargan, Samira Mohammadi-Yeganeh","doi":"10.1155/bmri/7109372","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background and Objectives:</b> Herpes simplex virus (HSV), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV) infections pose significant challenges in managing transplant patients and necessitate rapid and precise diagnostic methods due to their immunosuppressed state. This study designed and evaluated the performance of an in-house multiplex real-time PCR for simultaneous detection of these viruses. <b>Materials and Methods:</b> Plasma samples from 270 transplant patients were tested using an in-house multiplex real-time PCR assay specifically designed for HSV, VZV, and EBV. Analytical specificity and the assay's limit of detection (LOD) were determined. Statistical analyses were performed to evaluate the agreement between the in-house assay and the reference kit. <b>Results:</b> The method had a specificity of 98% for HSV, 97% for VZV, and 95% for EBV, alongside 100% sensitivity for all three viruses. No cross-reactivity was observed with other viral or bacterial DNA. The LOD for the in-house assay was determined to be 6.25, 25, and 25 copies/mL for HSV, VZV, and EBV, respectively. Additionally, precision analysis showed low CV values in both intra-assay and interassay evaluations (HSV: 1.5%-1.8%; VZV: 2.3%-2.6%; and EBV: 3.7%-3.9%), confirming the assay's robust analytical precision. Bland-Altman analysis showed mean differences of 1.35, -3.29, and 1.75 for HSV, VZV, and EBV, respectively. This multiplex real-time PCR method enables detection at lower concentrations. Cross-reactivity testing confirmed no interaction with DNA from other viruses or nontarget microorganisms. Bland-Altman and linear regression analyses also showed a strong agreement between commercial and in-house methods. <b>Conclusion:</b> These findings, compared to Altona diagnostic kits, highlight the value of designing and applying advanced diagnostic assays in managing viral infections in transplant patients.</p>","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2025 ","pages":"7109372"},"PeriodicalIF":2.3000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454909/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of an In-House Multiplex Real-Time PCR Method With Altona Diagnostics Kits in the Detection of HSV, VZV, and EBV Viruses in Transplant Patients.\",\"authors\":\"Reyhaneh Kalhor, Mahdi Paryan, Sirous Naeimi, Hourieh Kalhor, Hassan Noorbazargan, Samira Mohammadi-Yeganeh\",\"doi\":\"10.1155/bmri/7109372\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background and Objectives:</b> Herpes simplex virus (HSV), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV) infections pose significant challenges in managing transplant patients and necessitate rapid and precise diagnostic methods due to their immunosuppressed state. This study designed and evaluated the performance of an in-house multiplex real-time PCR for simultaneous detection of these viruses. <b>Materials and Methods:</b> Plasma samples from 270 transplant patients were tested using an in-house multiplex real-time PCR assay specifically designed for HSV, VZV, and EBV. Analytical specificity and the assay's limit of detection (LOD) were determined. Statistical analyses were performed to evaluate the agreement between the in-house assay and the reference kit. <b>Results:</b> The method had a specificity of 98% for HSV, 97% for VZV, and 95% for EBV, alongside 100% sensitivity for all three viruses. No cross-reactivity was observed with other viral or bacterial DNA. The LOD for the in-house assay was determined to be 6.25, 25, and 25 copies/mL for HSV, VZV, and EBV, respectively. Additionally, precision analysis showed low CV values in both intra-assay and interassay evaluations (HSV: 1.5%-1.8%; VZV: 2.3%-2.6%; and EBV: 3.7%-3.9%), confirming the assay's robust analytical precision. Bland-Altman analysis showed mean differences of 1.35, -3.29, and 1.75 for HSV, VZV, and EBV, respectively. This multiplex real-time PCR method enables detection at lower concentrations. Cross-reactivity testing confirmed no interaction with DNA from other viruses or nontarget microorganisms. Bland-Altman and linear regression analyses also showed a strong agreement between commercial and in-house methods. <b>Conclusion:</b> These findings, compared to Altona diagnostic kits, highlight the value of designing and applying advanced diagnostic assays in managing viral infections in transplant patients.</p>\",\"PeriodicalId\":9007,\"journal\":{\"name\":\"BioMed Research International\",\"volume\":\"2025 \",\"pages\":\"7109372\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-09-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12454909/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BioMed Research International\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1155/bmri/7109372\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioMed Research International","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1155/bmri/7109372","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景与目的:单纯疱疹病毒(HSV)、水痘带状疱疹病毒(VZV)和eb病毒(EBV)感染由于其免疫抑制状态,给移植患者的管理带来了重大挑战,需要快速准确的诊断方法。本研究设计并评估了用于同时检测这些病毒的内部多重实时PCR的性能。材料和方法:使用专为HSV, VZV和EBV设计的内部多重实时PCR检测270例移植患者的血浆样本。测定了该方法的分析特异性和检出限。进行统计分析以评估内部分析与参考试剂盒之间的一致性。结果:该方法对HSV的特异性为98%,对VZV的特异性为97%,对EBV的特异性为95%,对所有三种病毒的敏感性均为100%。未观察到与其他病毒或细菌DNA的交叉反应。测定HSV、VZV和EBV的LOD分别为6.25、25和25拷贝/mL。此外,精密度分析显示,在测定内和测定间的CV值都很低(HSV: 1.5%-1.8%; VZV: 2.3%-2.6%; EBV: 3.7%-3.9%),证实了该方法的可靠分析精度。Bland-Altman分析显示,HSV、VZV和EBV的平均差异分别为1.35、-3.29和1.75。这种多重实时PCR方法可以在较低浓度下进行检测。交叉反应性检测证实与其他病毒或非靶微生物的DNA无相互作用。Bland-Altman和线性回归分析也显示了商业方法和内部方法之间的强烈一致性。结论:与Altona诊断试剂盒相比,这些发现突出了设计和应用先进的诊断检测方法在管理移植患者病毒感染方面的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of an In-House Multiplex Real-Time PCR Method With Altona Diagnostics Kits in the Detection of HSV, VZV, and EBV Viruses in Transplant Patients.

Background and Objectives: Herpes simplex virus (HSV), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV) infections pose significant challenges in managing transplant patients and necessitate rapid and precise diagnostic methods due to their immunosuppressed state. This study designed and evaluated the performance of an in-house multiplex real-time PCR for simultaneous detection of these viruses. Materials and Methods: Plasma samples from 270 transplant patients were tested using an in-house multiplex real-time PCR assay specifically designed for HSV, VZV, and EBV. Analytical specificity and the assay's limit of detection (LOD) were determined. Statistical analyses were performed to evaluate the agreement between the in-house assay and the reference kit. Results: The method had a specificity of 98% for HSV, 97% for VZV, and 95% for EBV, alongside 100% sensitivity for all three viruses. No cross-reactivity was observed with other viral or bacterial DNA. The LOD for the in-house assay was determined to be 6.25, 25, and 25 copies/mL for HSV, VZV, and EBV, respectively. Additionally, precision analysis showed low CV values in both intra-assay and interassay evaluations (HSV: 1.5%-1.8%; VZV: 2.3%-2.6%; and EBV: 3.7%-3.9%), confirming the assay's robust analytical precision. Bland-Altman analysis showed mean differences of 1.35, -3.29, and 1.75 for HSV, VZV, and EBV, respectively. This multiplex real-time PCR method enables detection at lower concentrations. Cross-reactivity testing confirmed no interaction with DNA from other viruses or nontarget microorganisms. Bland-Altman and linear regression analyses also showed a strong agreement between commercial and in-house methods. Conclusion: These findings, compared to Altona diagnostic kits, highlight the value of designing and applying advanced diagnostic assays in managing viral infections in transplant patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BioMed Research International
BioMed Research International BIOTECHNOLOGY & APPLIED MICROBIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
6.70
自引率
0.00%
发文量
1942
审稿时长
19 weeks
期刊介绍: BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies covering a wide range of subjects in life sciences and medicine. The journal is divided into 55 subject areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信